Masahide Kuroki

Fukuoka University — Japan

Medicine · Health Sciences

36h-index4.1kcitations190works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Monoclonal and Polyclonal Antibodies Research(75), Glycosylation and Glycoproteins Research(30), Radiopharmaceutical Chemistry and Applications(30), HER2/EGFR in Cancer Research(21), CAR-T cell therapy research(18)

Publications190 total

Supplementary Tables 1-6 from Molecular Hierarchy of Heparin-Binding EGF-like Growth Factor–Regulated Angiogenesis in Triple-Negative Breast Cancer
2023Open Access
Supplementary Figures 1-4 from Molecular Hierarchy of Heparin-Binding EGF-like Growth Factor–Regulated Angiogenesis in Triple-Negative Breast Cancer
2023Open Access
Supplementary Figures 1-4 from Molecular Hierarchy of Heparin-Binding EGF-like Growth Factor–Regulated Angiogenesis in Triple-Negative Breast Cancer
2023Open Access
Supplementary Materials and Methods from Molecular Hierarchy of Heparin-Binding EGF-like Growth Factor–Regulated Angiogenesis in Triple-Negative Breast Cancer
2023Open Access
Data from Molecular Hierarchy of Heparin-Binding EGF-like Growth Factor–Regulated Angiogenesis in Triple-Negative Breast Cancer
2023Open Access
Supplementary Tables 1-6 from Molecular Hierarchy of Heparin-Binding EGF-like Growth Factor–Regulated Angiogenesis in Triple-Negative Breast Cancer
2023Open Access
Data from Molecular Hierarchy of Heparin-Binding EGF-like Growth Factor–Regulated Angiogenesis in Triple-Negative Breast Cancer
2023Open Access
Supplementary Materials and Methods from Molecular Hierarchy of Heparin-Binding EGF-like Growth Factor–Regulated Angiogenesis in Triple-Negative Breast Cancer
2023Open Access
Highly versatile cancer photoimmunotherapy using photosensitizer-conjugated avidin and biotin-conjugated targeting antibodies
Cancer Cell International·2019· 17 citedOpen Access
光増感剤共役アビジンおよびビオチン抱合標的抗体を用いた高度に多用途な癌光免疫療法【JST・京大機械翻訳】
2019
Association of Serum HB-EGF Value and Response to Chemotherapy in Patients with Recurrent Ovarian Cancer
Anticancer Research·2018· 5 citedOpen Access
The Long Noncoding RNA OIP5-AS1 Is Involved in the Regulation of Cell Proliferation
Anticancer Research·2018· 34 citedOpen Access
CEACAM5 (carcinoembryonic antigen-related cell adhesion molecule 5 (carcinoembryonic antigen))
Atlas of Genetics and Cytogenetics in Oncology and Haematology·2017· 2 citedOpen Access
Enhancement of antitumor activity by using a fully human gene encoding a single-chain fragmented antibody specific for carcinoembryonic antigen
OncoTargets and Therapy·2017· 8 citedOpen Access
Serum Heparin-binding Epidermal Growth Factor-like Growth Factor (HB-EGF) as a Biomarker for Primary Ovarian Cancer
Anticancer Research·2017· 17 citedOpen Access
A Modified Adenovirus Vector–Mediated Antibody Screening Method Identifies EphA2 as a Cancer Target
Translational Oncology·2017· 7 citedOpen Access
BK-UM in patients with recurrent ovarian cancer or peritoneal cancer: a first-in-human phase-I study
BMC Cancer·2017· 12 citedOpen Access
再発卵巣癌または腹膜癌患者におけるBK-UM ヒト第一相試験【JST・京大機械翻訳】
BMC Cancer (Web)·2017
Anti-tumor Effect of Intravenous Administration of CRM197 for Triple-negative Breast Cancer Therapy.
PubMed·2016· 14 cited
Validity of HB-EGF as Target for Human Neuroblastoma Therapy.
PubMed·2015· 3 cited
page 1 of 10Next →

Frequent Co-authors

Motomu Kuroki(16), Hirotomo Shibaguchi(9), Yuichi Yamashita(9), Hiromi Yamada(8), Senji Shirasawa(8), Hironori Abe(7), Yuji Matsuoka(7), Takayuki Shirakusa(7), Shingo Miyamoto(7), Yasushi Yamauchi(7), Toshiyuki Tsunoda(7), Keiko Doi(7), Fusanori Yotsumoto(6), Takahiro Fujimoto(6), Yasuhiro Yoshida(6), Motomu Kuroki(5), Midori Koyanagi(5), Takayuki Imakiire(5), Shinichi Maekawa(4), Tetsushi Kinugasa(4)